Dr Eva Maria Compérat is a renowned professor of Urologic Pathology at the Medical University of Vienna and the head of the Department of Pathology at the Hôpital Tenon, Sorbonne University in Paris. She has made significant contributions to the field of Uropathology and has published several works in this area. Her research focuses on Bladder cancer/urothelial carcinomas and the early events of bladder cancer development, Upper urinary tract carcinomas, prostate cancer, and kidney cancer. Dr. Compérat, along with her research group at Sorbonne University and in collaboration with the Medical University of Vienna, is currently working on investigating the microenvironment of prostate cancer as well as predictive and prognostic markers in prostate cancer. This study aims to spare patients from radical prostatectomy. Dr. Compérat is a well-known European Association of Urology (EAU) member and a board member of the Austrian Society of Pathology (ÖGP). Since 2021, she has served on the editorial board of Nature Reviews Urology and other editorials. One of her significant works is published in the WHO 5th 2022 Ed as a coauthor and responsible author of several chapters.